HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ron H J Mathijssen Selected Research

Ron H J Mathijssen Research Topics

Disease

112Neoplasms (Cancer)
02/2024 - 01/2002
31Breast Neoplasms (Breast Cancer)
03/2024 - 08/2003
24Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 05/2014
23Prostatic Neoplasms (Prostate Cancer)
03/2024 - 06/2015
16Neutropenia
02/2024 - 12/2004
16Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 02/2011
12Neoplasm Metastasis (Metastasis)
05/2024 - 01/2012
9Colorectal Neoplasms (Colorectal Cancer)
02/2023 - 06/2002
8Lung Neoplasms (Lung Cancer)
02/2023 - 08/2013
7Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2023 - 02/2011
7Ovarian Neoplasms (Ovarian Cancer)
02/2023 - 06/2002
7Melanoma (Melanoma, Malignant)
01/2023 - 01/2019
7Cancer Pain
06/2021 - 10/2015
7Sarcoma (Soft Tissue Sarcoma)
01/2020 - 10/2012
6Hypertension (High Blood Pressure)
11/2023 - 12/2014
5Disease Progression
04/2024 - 02/2011
5Diarrhea
01/2019 - 09/2002
4Leukopenia
10/2021 - 09/2009
4Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 02/2019
4Circulating Neoplastic Cells
08/2019 - 12/2015
3Body Weight (Weight, Body)
03/2024 - 01/2020
3Peritoneal Diseases
01/2024 - 02/2023
3Hand-Foot Syndrome
03/2023 - 09/2009
3Proteinuria
01/2023 - 12/2014
3Febrile Neutropenia
01/2023 - 04/2011
3Hepatocellular Carcinoma (Hepatoma)
09/2022 - 02/2011
3Fibrosis (Cirrhosis)
03/2022 - 10/2020
3Nausea
01/2015 - 09/2006
2Stomach Neoplasms (Stomach Cancer)
05/2024 - 02/2023
2Mesothelioma
01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

31Irinotecan (Camptosar)FDA LinkGeneric
04/2024 - 01/2002
24TamoxifenFDA LinkGeneric
03/2024 - 01/2011
17Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 08/2012
154-hydroxy-N-desmethyltamoxifenIBA
03/2024 - 08/2011
15Docetaxel (Taxotere)FDA Link
03/2024 - 03/2007
15Sunitinib (Sutent)FDA Link
11/2023 - 09/2009
15cabazitaxelFDA Link
11/2023 - 06/2015
14Cytochrome P-450 CYP3AIBA
01/2023 - 07/2002
11Androgen Receptors (Androgen Receptor)IBA
03/2024 - 06/2015
10Biomarkers (Surrogate Marker)IBA
03/2024 - 06/2011
10Tyrosine Kinase InhibitorsIBA
12/2023 - 02/2011
9Immune Checkpoint InhibitorsIBA
11/2023 - 10/2019
9NivolumabIBA
01/2023 - 01/2017
8Phosphotransferases (Kinase)IBA
02/2023 - 01/2013
8Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2003
7enzalutamideIBA
12/2023 - 06/2015
7Carboplatin (JM8)FDA LinkGeneric
01/2021 - 01/2013
6Cytochrome P-450 CYP2D6 (CYP2D6)IBA
03/2024 - 08/2011
6Capecitabine (Xeloda)FDA Link
03/2023 - 03/2015
6Antineoplastic Agents (Antineoplastics)IBA
01/2023 - 06/2002
6pembrolizumabIBA
01/2023 - 10/2018
6EnzymesIBA
01/2022 - 08/2003
6pazopanibFDA Link
01/2020 - 01/2016
6Imatinib Mesylate (Gleevec)FDA Link
10/2019 - 02/2011
6Fentanyl (Sublimaze)FDA LinkGeneric
11/2018 - 10/2015
5Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2024 - 06/2011
5DNA (Deoxyribonucleic Acid)IBA
02/2024 - 01/2013
5abirateroneIBA
12/2023 - 06/2015
5alectinibIBA
02/2023 - 01/2023
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 02/2012
5Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2022 - 08/2003
4osimertinibIBA
04/2024 - 01/2022
4Taxoids (Taxanes)IBA
11/2023 - 09/2015
4ErbB Receptors (EGF Receptor)IBA
05/2023 - 10/2020
4PlatinumIBA
01/2023 - 02/2011
4Esomeprazole (Nexium)FDA Link
11/2022 - 04/2016
4Messenger RNA (mRNA)IBA
01/2021 - 06/2014
4Opioid Analgesics (Opioids)IBA
11/2018 - 10/2015
4MicroRNAs (MicroRNA)IBA
11/2015 - 05/2014
3Hormones (Hormone)IBA
03/2024 - 03/2015
3darolutamideIBA
03/2024 - 06/2023
3AndrogensIBA
12/2023 - 11/2021
3taxaneIBA
11/2023 - 01/2019
3Anaplastic Lymphoma KinaseIBA
02/2023 - 01/2023
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 01/2021
3Pemetrexed (MTA)FDA Link
01/2023 - 10/2021
3AntibodiesIBA
01/2023 - 01/2020
3Sorafenib (BAY 43-9006)FDA Link
09/2022 - 02/2011
3TeaIBA
07/2022 - 11/2020
3Erythromycin (Erycette)FDA LinkGeneric
01/2022 - 01/2013
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021 - 08/2003
3Programmed Cell Death 1 ReceptorIBA
01/2021 - 10/2018
3Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 05/2011
3Midazolam (Versed)FDA LinkGeneric
03/2013 - 10/2005
3Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
09/2007 - 08/2003
2Circulating Tumor DNAIBA
04/2024 - 02/2024
2sotorasibIBA
04/2024 - 03/2024
2Estrogen ReceptorsIBA
03/2024 - 02/2021
2Bevacizumab (Avastin)FDA Link
01/2024 - 01/2020
2Angiogenesis InhibitorsIBA
11/2023 - 12/2014
2Therapeutic UsesIBA
01/2023 - 08/2007
2Cell-Free Nucleic AcidsIBA
01/2023 - 12/2019
2AntigensIBA
01/2023 - 01/2023

Therapy/Procedure

27Therapeutics
03/2024 - 02/2008
22Drug Therapy (Chemotherapy)
05/2024 - 08/2003
16Castration
06/2023 - 06/2015
4Drug Tapering
01/2020 - 01/2019
3Immunotherapy
03/2024 - 01/2020
2Hyperthermic Intraperitoneal Chemotherapy
10/2023 - 12/2019
2Cytoreduction Surgical Procedures
10/2023 - 12/2019